Stockreport

BRIEF-Contravir Pharma Files For Series C Convertible Preferred Stock [Reuters]

CONTRAVIR PHARMACEUTICALS INC  (CTRV) 
US:NASDAQ Investor Relations: ir.contravir.com/investor-relations
PDF BRIEF-Contravir Pharma Files For Series C Convertible Preferred Stock | Reuters Reuters Staff 1 Min Read May 18 (Reuters) - ContraVir Pharmaceuticals Inc: * CONTRAVIR PH [Read more]